Jentadueto XR is a prescription medication formulated to improve glycemic control in adults with type 2 diabetes mellitus. Its primary therapeutic role is to enhance the efficacy of existing antidiabetic regimens when additional glucose lowering is needed. The drug combines two active ingredients that work through complementary mechanisms to promote glucose homeostasis. One component is an extended-release formulation of linagliptin which provides sustained inhibition of the enzyme dipeptidyl peptidase-4. This inhibition increases levels of incretin hormones such as glp-1, leading to enhanced insulin secretion and reduced glucagon release. The combined effect of improved insulin action and lowered glucagon results in decreased hepatic glucose production and increased peripheral glucose uptake.

Jentadueto XR is a prescription medication used to improve blood sugar control in adults with type 2 diabetes. It contains the two active ingredients linagliptin and metformin formulated for extended release. Linagliptin blocks the enzyme dipeptidyl peptidase-4 increasing levels of incretin hormones. Higher incretin activity stimulates insulin secretion from the pancreas and reduces glucagon release. Metformin decreases glucose production in the liver and improves the body's response to insulin. Together the ingredients provide complementary mechanisms that lower fasting and post-meal glucose levels. The extended-release design allows steady drug levels throughout the day supporting consistent glycemic control. The combined effect helps maintain target blood glucose levels effectively.

Common side effects of Jentadueto XR include nausea, diarrhea, and abdominal discomfort. Some patients may experience headache or dizziness. Infrequent occurrences are coughing or upper respiratory infections. Hypoglycemia can happen, especially when used with other diabetes medications. Rare but serious effects involve pancreatitis and severe allergic reactions. Patients should be aware that these symptoms may vary and should monitor their health closely.

Some users may experience nausea or stomach discomfort after taking Jentadueto XR. Headache and dizziness are also reported side effects. Occasionally, low blood sugar levels can occur, especially when combined with other diabetes medications. Swelling of the hands or feet may indicate fluid retention. Rarely, allergic reactions such as rash or itching can develop. Changes in kidney function have been observed in some patients taking the medication.